ConductScience.org, home

Paper37561596

Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in mice.

Spanier JA and 14 others. J Clin Invest, 2023. Cited by 84 papers, by iCite.

Cite this record

ConductScience Library. Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in mice. Papers, record 37561596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37561596

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in mice.
PubMed
Journal
J Clin Invest
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
84
iCite
Relative citation ratio, by iCite
6.96
iCite
Revised in PubMed
2025-04-04
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Spanier JAJustin A
2Fung VVivian
3Wardell CMChristine M
4Alkhatib MHMohannad H
5Chen YYixin
6Swanson LALinnea A
7Dwyer AJAlexander J
8Weno MEMatthew E
9Silva NNubia
10Mitchell JSJason S
11Orban PCPaul C
12Mojibian MMajid
13Verchere CBC Bruce
14Fife BTBrian T
15Levings MKMegan K

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes Mellitus, Type 1Major topic
Receptors, Chimeric AntigenMajor topic
Mice
Animals
Histocompatibility Antigens Class II
Mice, Inbred NOD
Insulin
T-Lymphocytes, Regulatory

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
T32 AI007313NIAID NIH HHSUnited StatesT32AI007313PubMedNIH RePORTER
R21 AI166475NIAID NIH HHSUnited StatesR21AI166475PubMed and NIHNIH RePORTER
R01 AI106791NIAID NIH HHSUnited StatesR01AI106791PubMed and NIHNIH RePORTER
P01 AI035296NIAID NIH HHSUnited StatesP01AI035296PubMed and NIHNIH RePORTER
T35 AI118620NIAID NIH HHSUnited StatesT35AI118620PubMedNIH RePORTER
R01 AI156276NIAID NIH HHSUnited StatesR01AI156276PubMed and NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of36865264

Source PubMed

Download CSV of comments and corrections

References65

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134433860Enhanced CD4+ and CD8+ T cell infiltrate within convex hull defined pancreatic islet borders as autoimmune diabetes progresses.Sci Rep2021https://conductscience.org/library/papers/34433860PubMed
28671665Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.Int Immunol1996https://conductscience.org/library/papers/8671665PubMed
336197963Pancreatic islet-specific engineered Tregs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models.Sci Transl Med2022https://conductscience.org/library/papers/36197963PubMed
428027623Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.Am J Transplant2017https://conductscience.org/library/papers/28027623PubMed
512415259Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis.Nat Med2002https://conductscience.org/library/papers/12415259PubMed
624686242Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells.Mol Ther2014https://conductscience.org/library/papers/24686242PubMed
730753169Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells.JCI Insight2019https://conductscience.org/library/papers/30753169PubMed
830730852Treg gene signatures predict and measure type 1 diabetes trajectory.JCI Insight2019https://conductscience.org/library/papers/30730852PubMed
916116193Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice.J Immunol2005https://conductscience.org/library/papers/16116193PubMed
1033053469Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression.Cell Immunol2020https://conductscience.org/library/papers/33053469PubMed
1122102287A single autoimmune T cell receptor recognizes more than a million different peptides.J Biol Chem2012https://conductscience.org/library/papers/22102287PubMed
1231176558Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.J Autoimmun2019https://conductscience.org/library/papers/31176558PubMed
1311137993The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.Nat Genet2001https://conductscience.org/library/papers/11137993PubMed
1429133420Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD mice.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/29133420PubMed
1527292946Efficient generation of monoclonal antibodies against peptide in the context of MHCII using magnetic enrichment.Nat Commun2016https://conductscience.org/library/papers/27292946PubMed
1625632005A transendocytosis model of CTLA-4 function predicts its suppressive behavior on regulatory T cells.J Immunol2015https://conductscience.org/library/papers/25632005PubMed
1715855327Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes.Diabetes2005https://conductscience.org/library/papers/15855327PubMed
1822723342Administration of CD4+CD25highCD127- regulatory T cells preserves β-cell function in type 1 diabetes in children.Diabetes Care2012https://conductscience.org/library/papers/22723342PubMed
1915184499In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.J Exp Med2004https://conductscience.org/library/papers/15184499PubMed
2028117148Generation of human islet-specific regulatory T cells by TCR gene transfer.J Autoimmun2017https://conductscience.org/library/papers/28117148PubMed

See all 65 referencesDownload CSV of references

Cited by60

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.

PMIDTitleJournalYearIn PapersSource
42799027Bioengineered T-cell therapies for precision immunotherapy in renal transplantation, autoimmune relapse, and sensitization.Clin Kidney J2025https://conductscience.org/library/papers/42799027PubMed
42694788FOXP3 Stability-Adaptation Paradox: Reshaping Treg-Based Therapies for Intestinal Diseases.Int J Biol Sci2026https://conductscience.org/library/papers/42694788PubMed
42675035Regulatory T cell induction strategies and applications in the treatment of immune and non-immune diseases.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42675035PubMed
42661942Regulatory T cells in autoimmune diseases: biological mechanisms, clinical translation, and translational challenges.Front Immunol2026https://conductscience.org/library/papers/42661942PubMed
42598543The Role of Chimeric Antigen Receptor Regulatory T Cells in Promoting Immune Tolerance in Solid Organ Transplantation: Mechanisms and Therapeutic Potential.Saudi Med J2026https://conductscience.org/library/papers/42598543PubMed
42584417Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy.J Exp Med2026https://conductscience.org/library/papers/42584417PubMed
42317359Chimeric antigen receptor technology: an emerging translational immunotherapy in nonneoplastic diseases.Front Immunol2026https://conductscience.org/library/papers/42317359PubMed
42225638Regulatory T cells in cancer and inflammation.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42225638PubMed
42158317Chimeric Antigen Receptor T-Cell Revolution Remodeling Immunity to Conquer Autoimmune Disease.Research (Wash D C)2026https://conductscience.org/library/papers/42158317PubMed
42074260Targeting the pMHC-TCR Interaction: Molecular Strategies and Therapeutic Potential in Autoimmunity.Int J Mol Sci2026https://conductscience.org/library/papers/42074260PubMed
41958676Role of Treg cells in diabetes mellitus and association with traditional Chinese medicine: a literature review.Front Immunol2026https://conductscience.org/library/papers/41958676PubMed
41777899Modulating immune response for the prevention and treatment of type 1 diabetes.Front Immunol2026https://conductscience.org/library/papers/41777899PubMed
41635853Oral tolerogenic vaccine combined with gastrin restores immune tolerance and beta-cell function in NOD mice with Type 1 diabetes.Front Immunol2025https://conductscience.org/library/papers/41635853PubMed
41607801The immunobiology and therapeutic potential of regulatory T cells in autoimmune diseases and allergic diseases.Front Immunol2025https://conductscience.org/library/papers/41607801PubMed
41588112Roads and detours for CAR T cell therapy in autoimmune diseases.Nat Rev Drug Discov2026https://conductscience.org/library/papers/41588112PubMed
41366793Convergence of mRNA technology and chimeric antigen receptor therapy: targeted technology optimizing targeted therapy.J Transl Med2025https://conductscience.org/library/papers/41366793PubMed
41316450Challenges and strategies in clinical applications of CAR-T therapy for autoimmune diseases.J Hematol Oncol2025https://conductscience.org/library/papers/41316450PubMed
41294856Improvement of Treg Selectivity and Stability for Diabetes Mellitus Type 1 Treatment: Complex Approach for Perspective Technologies.Cells2025https://conductscience.org/library/papers/41294856PubMed
41235222Opportunities and challenges harnessing antigen-specific CD4+ regulatory T cells in inflammatory bowel disease.Front Immunol2025https://conductscience.org/library/papers/41235222PubMed
41226824Unraveling Type 1 Diabetes: Integrating Microbiome, Metabolomics, and Immunomodulation for Next-Generation Therapies.Int J Mol Sci2025https://conductscience.org/library/papers/41226824PubMed

See all 60 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
FOXP350943PubTator's text mininghttps://conductscience.org/library/genes/50943NCBI Gene
G6PC257818PubTator's text mininghttps://conductscience.org/library/genes/57818NCBI Gene
NR1I39970PubTator's text mininghttps://conductscience.org/library/genes/9970NCBI Gene
SCFV652070PubTator's text mininghttps://conductscience.org/library/genes/652070NCBI Gene
TRBV20OR9-26962PubTator's text mininghttps://conductscience.org/library/genes/6962NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37561596

GET https://conductscience.org/api/papers/v1/37561596/references?page=2